Mosaic Immunoengineering Stock Current Ratio
| CPMV Stock | USD 0.61 0.39 39.00% |
Mosaic Immunoengineering fundamentals help investors to digest information that contributes to Mosaic Immunoengineerin's financial success or failures. It also enables traders to predict the movement of Mosaic OTC Stock. The fundamental analysis module provides a way to measure Mosaic Immunoengineerin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mosaic Immunoengineerin otc stock.
Mosaic |
Mosaic Immunoengineering OTC Stock Current Ratio Analysis
Mosaic Immunoengineerin's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Mosaic Immunoengineerin Current Ratio | 0.07 X |
Most of Mosaic Immunoengineerin's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mosaic Immunoengineering is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Mosaic Immunoengineering has a Current Ratio of 0.07 times. This is 97.59% lower than that of the Healthcare sector and 99.0% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 96.76% higher than that of the company.
Mosaic Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mosaic Immunoengineerin's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mosaic Immunoengineerin could also be used in its relative valuation, which is a method of valuing Mosaic Immunoengineerin by comparing valuation metrics of similar companies.Mosaic Immunoengineerin is currently under evaluation in current ratio category among its peers.
Mosaic Fundamentals
| Return On Asset | -4.2 | |||
| Current Valuation | 10.22 M | |||
| Shares Outstanding | 7.24 M | |||
| Shares Owned By Insiders | 88.73 % | |||
| Price To Book | 9.33 X | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.68 M) | |||
| Cash And Equivalents | 205.99 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 735.15 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.60) X | |||
| Cash Flow From Operations | (679.24 K) | |||
| Earnings Per Share | (0.51) X | |||
| Beta | -1.79 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 269.49 K | |||
| Z Score | -38.1 | |||
| Net Asset | 269.49 K |
About Mosaic Immunoengineerin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mosaic Immunoengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mosaic Immunoengineerin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mosaic Immunoengineering based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.